Phase II study of pemetrexed and carboplatin plus bevacizumab as first-line therapy in malignant pleural mesothelioma (Q37081896)
Jump to navigation
Jump to search
scientific article published on 16 July 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase II study of pemetrexed and carboplatin plus bevacizumab as first-line therapy in malignant pleural mesothelioma |
scientific article published on 16 July 2013 |
Statements
1 reference
Phase II study of pemetrexed and carboplatin plus bevacizumab as first-line therapy in malignant pleural mesothelioma (English)
1 reference
G L Ceresoli
1 reference
P A Zucali
1 reference
M Mencoboni
1 reference
M Botta
1 reference
F Grossi
1 reference
D Cortinovis
1 reference
N Zilembo
1 reference
C Ripa
1 reference
M Tiseo
1 reference
A G Favaretto
1 reference
H Soto-Parra
1 reference
F De Vincenzo
1 reference
A Bruzzone
1 reference
E Lorenzi
1 reference
L Gianoncelli
1 reference
B Ercoli
1 reference
L Giordano
1 reference
A Santoro
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference